[HTML][HTML] Platelet activation in critically ill COVID-19 patients
Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
Platelet activation in critically ill COVID-19 patients.
N Yatim, J Boussier, R Chocron… - … of Intensive Care, 2021 - search.ebscohost.com
Background: Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
Platelet activation in critically ill COVID-19 patients
N Yatim, J Boussier, R Chocron… - Annals of …, 2021 - sorbonne-paris-nord.hal.science
Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
[PDF][PDF] Platelet activation in critically ill COVID-19 patients
N Yatim, J Boussier, R Chocron12, J Hadjadj… - 2021 - scholar.archive.org
Background: Microvascular, arterial and venous thrombotic events have been largely
described during severe coro‑navirus disease 19 (COVID‑19). However, mechanisms …
described during severe coro‑navirus disease 19 (COVID‑19). However, mechanisms …
[HTML][HTML] Platelet activation in critically ill COVID-19 patients
N Yatim, J Boussier, R Chocron, J Hadjadj… - Annals of Intensive …, 2021 - ncbi.nlm.nih.gov
Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
Platelet activation in critically ill COVID-19 patients.
N Yatim, J Boussier, R Chocron, J Hadjadj… - Annals of Intensive …, 2021 - europepmc.org
Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
Platelet activation in critically ill COVID-19 patients
N Yatim, J Boussier, R Chocron… - … of intensive care, 2021 - pubmed.ncbi.nlm.nih.gov
Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
Platelet activation in critically ill COVID-19 patients
Y Nader, B Jeremy, R Chocron, H Jérôme… - Annals of Intensive …, 2021 - search.proquest.com
Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
Platelet activation in critically ill COVID-19 patients
N Yatim, J Boussier, R Chocron, J Hadjadj… - Annals of Intensive …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Microvascular, arterial and venous thrombotic events have been largely described during …
Microvascular, arterial and venous thrombotic events have been largely described during …
Platelet activation in critically ill COVID-19 patients
N Yatim, J Boussier, R Chocron, J Hadjadj… - Annals of Intensive …, 2021 - pasteur.hal.science
Background Microvascular, arterial and venous thrombotic events have been largely
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …
described during severe coronavirus disease 19 (COVID-19). However, mechanisms …